CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 55 enrolled
Drug / intervention
Insertable Cardiac Monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04190186
NCT04190186N/ACompleted
CompareCT.gov

Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation (HYBRID AF)

University of Rochester·interventional·Posted Dec 9, 2019·Updated Jul 29, 2025

In Brief

A clinical study evaluating Insertable Cardiac Monitor for Persistent Atrial Fibrillation. Completed, enrolled 55 participants across 4 sites.

Detailed Summary

This clinical trial is designed to compare two management strategies for the treatment of asymptomatic/subclinical atrial fibrillation after ablation based on data from the Biotronik ICM (BioMonitor3® or future generation of Biotronik ICM).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPersistent Atrial Fibrillation
CountriesUnited States
CollaboratorsBiotronik, Inc.

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 9, 2019
Enrollment StartJun 25, 2020
Primary CompletionFeb 15, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 6.6 years ago

Interventions

Insertable Cardiac Monitordevice

Implantable device that provides accurate daily transmission of cardiac electrical data for arrhythmia detection.